Hydromer IncOver The Counter Market:HYDI
- LAST PRICE0.3500
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close--- / 0.3500
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
Oct 24, 2024
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for Third Quarter 2024, from 11:19AM ET on Thursday Oct 24, 2024 by Dow Jones
11:19AM ET on Thursday Oct 24, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Hydromer Inc | 1.7M | 2.5x | --- |
PV Nano Cell Ltd | 232.4K | 0.0x | --- |
Angstrom Technologies Inc | 5.7M | -5.9x | --- |
Premier Graphene Inc | 989.0K | 0.0x | --- |
Alkane Inc | 330.0 | --- | --- |
CleanTech Biofuels Inc | 100.0 | 0.0x | --- |
Company Information
Hydromer, Inc. is a provider of hydrophilic, thromboresistant, and antimicrobial coating technologies for medical devices. The Company is engaged in providing business-to- business (B2B) surface modification and coating solutions provider. The Company offers polymer research and development, and manufacturing services capabilities for a variety of applications. Its customers are located across North and South America, Europe, the Middle East, and Asia-Pacific. Its segments include Medical and Industrial. Medical segment provides medical coatings support to specialized FDA approved medical devices and medical coatings that reduce insertion and withdrawal friction and potential trauma and enhance the performance of medical devices used in anatomies of the human body. The Industrial segment provides customized anti-fog, anti-frost, and condensation-control coating solutions for a variety of applications on many substrates including polycarbonate, glass, metal, and polyurethane.
Contact Information
- Headquarters
- 4715 Corporate Dr.CONCORD, NC, United States 28027
- Phone
- 908-526-2828
- Fax
- 908-526-3633
Executives
- Chief Executive Officer, Director
- Michael Torti
- Chief Financial Officer, Vice President - Finance, Treasurer
- Robert Lee
- Director of Finance
- Cortney Wells
- Executive Vice President - Operations; President of Biosearch Medical Products
- Martin Dyck
- Vice President - Quality Assurance, Director - Human Resources
- John Konar
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.7M |
|---|---|
Revenue (TTM) | $1.3M |
Shares Outstanding | 4.8M |
Hydromer Inc does not pay a dividend. | |
Beta | -0.23 |
EPS | $0.14 |
Book Value | $-0.03 |
P/E Ratio | 2.5x |
Price/Sales (TTM) | 1.3 |
Price/Cash Flow (TTM) | 1.4x |
Operating Margin | 64.07% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
